 | | NO6 | | 表記: | S-[(pyridin-2-yl)methyl]-L-cysteine | | 組成式: | C9 H12 N2 O2 S | | SMILES: | O=C(O)C(N)CSCc1ccccn1 | | InChi: | InChI=1S/C9H12N2O2S/c10-8(9(12)13)6-14-5-7-3-1-2-4-11-7/h1-4,8H,5-6,10H2,(H,12,13)/t8-/m0/s1 | | 定義日: | 2022-04-06 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-08-30 | | 識別子(ID): | S-[(pyridin-2-yl)methyl]-L-cysteine |
|
 | | YLM | | 表記: | (1R,2S)-2-((S)-2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | | 組成式: | C21 H30 F N3 O8 S | | SMILES: | CC(C)CC(NC(=O)OCc1ccc(F)cc1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | | InChi: | InChI=1S/C21H30FN3O8S/c1-12(2)9-16(25-21(29)33-11-13-3-5-15(22)6-4-13)19(27)24-17(20(28)34(30,31)32)10-14-7-8-23-18(14)26/h3-6,12,14,16-17,20,28H,7-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t14-,16-,17-,20+/m0/s1 | | 定義日: | 2021-03-12 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-03-24 | | 識別子(ID): | (1R,2S)-2-[(N-{[(4-fluorophenyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | VDL | | 表記: | (2R,3R)-2,3-DIAMINOBUTANOIC ACID | | 組成式: | C4 H10 N2 O2 | | SMILES: | O=C(O)C(N)C(N)C | | InChi: | InChI=1S/C4H10N2O2/c1-2(5)3(6)4(7)8/h2-3H,5-6H2,1H3,(H,7,8)/t2-,3-/m1/s1 | | 別名: | D-ERITHRO-2,3-DIAMINO-BUTYRIC ACID | | 定義日: | 2004-07-16 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (2R,3R)-2,3-diaminobutanoic acid |
|
 | | NA4 | | 表記: | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID | | 組成式: | C17 H14 N2 O6 | | SMILES: | O=C(O)CC(C=O)NC(=O)c2cncc(c1ccc(C(=O)O)cc1)c2 | | InChi: | InChI=1S/C17H14N2O6/c20-9-14(6-15(21)22)19-16(23)13-5-12(7-18-8-13)10-1-3-11(4-2-10)17(24)25/h1-5,7-9,14H,6H2,(H,19,23)(H,21,22)(H,24,25)/t14-/m0/s1 | | 定義日: | 2003-11-19 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 4-(5-{[(1S)-2-carboxy-1-formylethyl]carbamoyl}pyridin-3-yl)benzoic acid |
|
 | | YLN | | 表記: | bis[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]-bis(oxidanyl)boranuide | | 組成式: | C10 H10 B F6 N4 O2 | | SMILES: | Cn1nc(cc1[B-](O)(O)c2cc(nn2C)C(F)(F)F)C(F)(F)F | | InChi: | InChI=1S/C10H10BF6N4O2/c1-20-7(3-5(18-20)9(12,13)14)11(22,23)8-4-6(10(15,16)17)19-21(8)2/h3-4,22-23H,1-2H3/q-1 | | 定義日: | 2023-06-19 | | 最終更新日: | 2024-09-27 | | 公開日: | 2024-01-24 | | 識別子(ID): | bis[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]-bis(oxidanyl)boranuide |
|
 | | ZNL | | 表記: | N-{7-methyl-1-[(3S)-1-(prop-2-enoyl)azepan-3-yl]-1H-benzimidazol-2-yl}-5-(prop-2-enamido)thiophene-3-carboxamide | | 組成式: | C25 H27 N5 O3 S | | SMILES: | O=C(Nc1nc2cccc(C)c2n1C1CCCCN(C1)C(=O)C=C)c1cc(NC(=O)C=C)sc1 | | InChi: | InChI=1S/C25H27N5O3S/c1-4-20(31)27-21-13-17(15-34-21)24(33)28-25-26-19-11-8-9-16(3)23(19)30(25)18-10-6-7-12-29(14-18)22(32)5-2/h4-5,8-9,11,13,15,18H,1-2,6-7,10,12,14H2,3H3,(H,27,31)(H,26,28,33)/t18-/m0/s1 | | 定義日: | 2022-09-28 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-10-18 | | 識別子(ID): | N-{7-methyl-1-[(3S)-1-(prop-2-enoyl)azepan-3-yl]-1H-benzimidazol-2-yl}-5-(prop-2-enamido)thiophene-3-carboxamide |
|
 | | A1IDO | | 表記: | ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(4-chlorophenyl)methyl]prop-2-enamide | | 組成式: | C21 H23 Cl N2 O2 | | SMILES: | N[CH]1CC[CH](C1)Oc2ccc(cc2)N(Cc3ccc(Cl)cc3)C(=O)C=C | | InChi: | InChI=1S/C21H23ClN2O2/c1-2-21(25)24(14-15-3-5-16(22)6-4-15)18-8-11-19(12-9-18)26-20-10-7-17(23)13-20/h2-6,8-9,11-12,17,20H,1,7,10,13-14,23H2/t17-,20-/m1/s1 | | 定義日: | 2024-06-06 | | 最終更新日: | 2024-09-27 | | 公開日: | 2024-10-02 | | 識別子(ID): | ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(4-chlorophenyl)methyl]prop-2-enamide |
|
 | | PQR | | 表記: | 4-[methyl(nitroso)amino]benzene-1,2-diol | | 組成式: | C7 H8 N2 O3 | | SMILES: | O=NN(c1cc(O)c(O)cc1)C | | InChi: | InChI=1S/C7H8N2O3/c1-9(8-12)5-2-3-6(10)7(11)4-5/h2-4,10-11H,1H3 | | 別名: | Methyl-3,4-dephostatin | | 定義日: | 2012-01-03 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 4-[methyl(nitroso)amino]benzene-1,2-diol |
|
 | | NA7 | | 表記: | [(2R,3R,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3-HYDROXY-4-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL [(2R,3S,4S)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN DIPHOSPHATE | | 組成式: | C15 H24 N5 O16 P3 | | SMILES: | O=P(O)(OCC1OCC(O)C1O)OP(=O)(O)OCC4OC(n3cnc2c(ncnc23)N)C(OP(=O)(O)O)C4O | | InChi: | InChI=1S/C15H24N5O16P3/c16-13-9-14(18-4-17-13)20(5-19-9)15-12(35-37(24,25)26)11(23)8(34-15)3-33-39(29,30)36-38(27,28)32-2-7-10(22)6(21)1-31-7/h4-8,10-12,15,21-23H,1-3H2,(H,27,28)(H,29,30)(H2,16,17,18)(H2,24,25,26)/t6-,7+,8+,10-,11+,12+,15+/m0/s1 | | 定義日: | 2006-11-15 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | [(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl]methyl [(2R,3S,4S)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
 | | UY7 | | 表記: | (4S)-4-hydroxy-D-proline | | 組成式: | C5 H9 N O3 | | SMILES: | C1C(O)CNC1C(O)=O | | InChi: | InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m0/s1 | | 定義日: | 2020-06-04 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-12-30 | | 識別子(ID): | (4S)-4-hydroxy-D-proline |
|
 | | XV1 | | 表記: | 7-(2-fluorobenzyl)quinolin-8-ol | | 組成式: | C16 H12 F N O | | SMILES: | Fc1ccccc1Cc2c(O)c3ncccc3cc2 | | InChi: | InChI=1S/C16H12FNO/c17-14-6-2-1-4-12(14)10-13-8-7-11-5-3-9-18-15(11)16(13)19/h1-9,19H,10H2 | | 定義日: | 2009-09-11 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 7-(2-fluorobenzyl)quinolin-8-ol |
|
 | | NA8 | | 表記: | (1S)-1-CARBOXY-2-NAPHTHALEN-2-YLETHANAMINIUM | | 組成式: | C13 H14 N O2 | | SMILES: | O=C(O)C([NH3+])Cc2ccc1c(cccc1)c2 | | InChi: | InChI=1S/C13H13NO2/c14-12(13(15)16)8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7,12H,8,14H2,(H,15,16)/p+1/t12-/m0/s1 | | 定義日: | 2009-10-22 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | (1S)-1-carboxy-2-naphthalen-2-ylethanaminium |
|
 | | VSC | | 表記: | N-[N'-BENZYLOXYCARBONYL-PHENYLALANINYL]-3-AMINO-5-PHENYL-PENTANE-1-SULFONIC ACID PHENYL ESTER | | 組成式: | C34 H36 N2 O6 S | | SMILES: | O=S(=O)(Oc1ccccc1)CCC(NC(=O)C(NC(=O)OCc2ccccc2)Cc3ccccc3)CCc4ccccc4 | | InChi: | InChI=1S/C34H36N2O6S/c37-33(32(25-28-15-7-2-8-16-28)36-34(38)41-26-29-17-9-3-10-18-29)35-30(22-21-27-13-5-1-6-14-27)23-24-43(39,40)42-31-19-11-4-12-20-31/h1-20,30,32H,21-26H2,(H,35,37)(H,36,38)/t30-,32-/m0/s1 | | 別名: | WRR-204 | | 定義日: | 2000-05-03 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | phenyl (3S)-3-({N-[(benzyloxy)carbonyl]-L-phenylalanyl}amino)-5-phenylpentane-1-sulfonate |
|
 | | YLS | | 表記: | (1S,2S)-2-((S)-2-((((4-fluorobenzyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | | 組成式: | C21 H30 F N3 O8 S | | SMILES: | CC(C)CC(NC(=O)OCc1ccc(F)cc1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | | InChi: | InChI=1S/C21H30FN3O8S/c1-12(2)9-16(25-21(29)33-11-13-3-5-15(22)6-4-13)19(27)24-17(20(28)34(30,31)32)10-14-7-8-23-18(14)26/h3-6,12,14,16-17,20,28H,7-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t14-,16-,17-,20-/m0/s1 | | 定義日: | 2021-03-12 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-03-24 | | 識別子(ID): | (1S,2S)-2-[(N-{[(4-fluorophenyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | RQZ | | 表記: | 3-[3-(propanoylamino)phenyl]-1~{H}-pyrrolo[2,3-b]pyridine-5-carboxamide | | 組成式: | C17 H16 N4 O2 | | SMILES: | CCC(=O)Nc1cccc(c1)c2c[nH]c3ncc(cc23)C(N)=O | | InChi: | InChI=1S/C17H16N4O2/c1-2-15(22)21-12-5-3-4-10(6-12)14-9-20-17-13(14)7-11(8-19-17)16(18)23/h3-9H,2H2,1H3,(H2,18,23)(H,19,20)(H,21,22) | | 定義日: | 2020-10-20 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-12-02 | | 識別子(ID): | 3-[3-(propanoylamino)phenyl]-1~{H}-pyrrolo[2,3-b]pyridine-5-carboxamide |
|
 | | UKS | | 表記: | [(1R)-4-phenyl-1-{[N-(pyrazine-2-carbonyl)-D-norvalyl]amino}butyl]boronic acid | | 組成式: | C20 H27 B N4 O4 | | SMILES: | C(CCC)(NC(c1cnccn1)=O)C(=O)NC(B(O)O)CCCc2ccccc2 | | InChi: | InChI=1S/C20H27BN4O4/c1-2-7-16(24-20(27)17-14-22-12-13-23-17)19(26)25-18(21(28)29)11-6-10-15-8-4-3-5-9-15/h3-5,8-9,12-14,16,18,28-29H,2,6-7,10-11H2,1H3,(H,24,27)(H,25,26)/t16-,18+/m1/s1 | | 定義日: | 2020-05-20 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-04-14 | | 識別子(ID): | [(1R)-4-phenyl-1-{[N-(pyrazine-2-carbonyl)-D-norvalyl]amino}butyl]boronic acid |
|
 | | UYA | | 表記: | (4R)-4-hydroxy-D-proline | | 組成式: | C5 H9 N O3 | | SMILES: | N1CC(CC1C(O)=O)O | | InChi: | InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4-/m1/s1 | | 定義日: | 2020-06-04 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-12-30 | | 識別子(ID): | (4R)-4-hydroxy-D-proline |
|
 | | VDQ | | 表記: | 4-morpholin-4-ylaniline | | 組成式: | C10 H14 N2 O | | SMILES: | Nc1ccc(cc1)N2CCOCC2 | | InChi: | InChI=1S/C10H14N2O/c11-9-1-3-10(4-2-9)12-5-7-13-8-6-12/h1-4H,5-8,11H2 | | 別名: | 4-Morpholinoaniline | | 定義日: | 2021-05-07 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-08-11 | | 識別子(ID): | 4-morpholin-4-ylaniline |
|
 | | LNR | | 表記: | L-NOREPINEPHRINE | | 組成式: | C8 H11 N O3 | | SMILES: | Oc1ccc(cc1O)C(O)CN | | InChi: | InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1 | | 別名: | NORADRENALINE | | 定義日: | 2001-03-28 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol |
|
 | | UKT | | 表記: | (1R,2R,3R,4S,5R)-4-(hydroxymethyl)cyclohexane-1,2,3,5-tetrol | | 組成式: | C7 H14 O5 | | SMILES: | OC[CH]1[CH](O)C[CH](O)[CH](O)[CH]1O | | InChi: | InChI=1S/C7H14O5/c8-2-3-4(9)1-5(10)7(12)6(3)11/h3-12H,1-2H2/t3-,4+,5+,6+,7+/m0/s1 | | 別名: | (1~{R},2~{R},3~{R},4~{S},5~{R})-4-(hydroxymethyl)cyclohexane-1,2,3,5-tetrol | | 定義日: | 2021-02-28 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-04-28 | | 識別子(ID): | (1~{R},2~{R},3~{R},4~{S},5~{R})-4-(hydroxymethyl)cyclohexane-1,2,3,5-tetrol |
|
 | | QYS | | 表記: | (1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | | 組成式: | C21 H35 F2 N3 O8 S | | SMILES: | C2(F)(CCC(COC(=O)NC(CC(C)C)C(NC(CC1C(=O)NCC1)C(S(=O)(=O)O)O)=O)CC2)F | | InChi: | InChI=1S/C21H35F2N3O8S/c1-12(2)9-15(26-20(30)34-11-13-3-6-21(22,23)7-4-13)18(28)25-16(19(29)35(31,32)33)10-14-5-8-24-17(14)27/h12-16,19,29H,3-11H2,1-2H3,(H,24,27)(H,25,28)(H,26,30)(H,31,32,33)/t14-,15-,16-,19?/m0/s1 | | 定義日: | 2020-01-15 | | 最終更新日: | 2024-09-27 | | 公開日: | 2020-07-08 | | 識別子(ID): | (1S,2S)-2-[(N-{[(4,4-difluorocyclohexyl)methoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | XV4 | | 表記: | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide | | 組成式: | C23 H32 N4 O5 | | SMILES: | C3(C(CC(NC(C(CC(C)C)NC(c1nc2c(c1)c(OC)ccc2)=O)=O)CO)CCN3)=O | | InChi: | InChI=1S/C23H32N4O5/c1-13(2)9-18(22(30)25-15(12-28)10-14-7-8-24-21(14)29)27-23(31)19-11-16-17(26-19)5-4-6-20(16)32-3/h4-6,11,13-15,18,26,28H,7-10,12H2,1-3H3,(H,24,29)(H,25,30)(H,27,31)/t14-,15-,18-/m0/s1 | | 定義日: | 2021-01-14 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-07-07 | | 識別子(ID): | N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide |
|
 | | LNT | | 表記: | N-[(2S)-2-amino-1,1-dihydroxy-4-methylpentyl]-L-threonine | | 組成式: | C10 H22 N2 O5 | | SMILES: | O=C(O)C(NC(O)(O)C(N)CC(C)C)C(O)C | | InChi: | InChI=1S/C10H22N2O5/c1-5(2)4-7(11)10(16,17)12-8(6(3)13)9(14)15/h5-8,12-13,16-17H,4,11H2,1-3H3,(H,14,15)/t6-,7+,8+/m1/s1 | | 定義日: | 2007-11-07 | | 最終更新日: | 2024-09-27 | | 識別子(ID): | N-[(2S)-2-amino-1,1-dihydroxy-4-methylpentyl]-L-threonine |
|
 | | YLV | | 表記: | (1R,2S)-1-hydroxy-2-((S)-4-methyl-2-((((perfluorophenyl)methoxy)carbonyl)amino)pentanamido)-3-((R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl)propane-1-sulfonic acid | | 組成式: | C21 H24 F5 N3 O8 S | | SMILES: | O=C1NC=CC1CC(NC(=O)C(CC(C)C)NC(=O)OCc1c(F)c(F)c(F)c(F)c1F)C(O)S(=O)(=O)O | | InChi: | InChI=1S/C21H24F5N3O8S/c1-8(2)5-11(29-21(33)37-7-10-13(22)15(24)17(26)16(25)14(10)23)19(31)28-12(20(32)38(34,35)36)6-9-3-4-27-18(9)30/h3-4,8-9,11-12,20,32H,5-7H2,1-2H3,(H,27,30)(H,28,31)(H,29,33)(H,34,35,36)/t9-,11-,12-,20+/m0/s1 | | 定義日: | 2021-03-12 | | 最終更新日: | 2024-09-27 | | 公開日: | 2021-03-24 | | 識別子(ID): | (1R,2S)-1-hydroxy-3-[(3R)-2-oxo-2,3-dihydro-1H-pyrrol-3-yl]-2-[(N-{[(pentafluorophenyl)methoxy]carbonyl}-L-leucyl)amino]propane-1-sulfonic acid |
|
 | | ZNT | | 表記: | 2'3'-cUA | | 組成式: | C19 H23 N7 O14 P2 | | SMILES: | Nc1ncnc2c1ncn2C1OC2COP(=O)(O)OC3C(OC(COP(=O)(O)OC2C1O)C3O)N1C=CC(=O)NC1=O | | InChi: | InChI=1S/C19H23N7O14P2/c20-15-10-16(22-5-21-15)26(6-23-10)17-12(29)13-8(38-17)4-36-42(33,34)40-14-11(28)7(3-35-41(31,32)39-13)37-18(14)25-2-1-9(27)24-19(25)30/h1-2,5-8,11-14,17-18,28-29H,3-4H2,(H,31,32)(H,33,34)(H2,20,21,22)(H,24,27,30)/t7-,8-,11-,12-,13-,14-,17-,18-/m1/s1 | | 別名: | 1-[(2R,5R,7R,8R,10S,12aR,14R,15R,15aS,16R)-14-(6-amino-9H-purin-9-yl)-2,10,15,16-tetrahydroxy-2,10-dioxooctahydro-2H,10H,12H-5,8-methano-2lambda~5~,10lambda~5~-furo[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecin-7-yl]pyrimidine-2,4(1H,3H)-dione | | 定義日: | 2023-03-17 | | 最終更新日: | 2024-09-27 | | 公開日: | 2023-07-05 | | 識別子(ID): | 1-[(2R,5R,7R,8R,10S,12aR,14R,15R,15aS,16R)-14-(6-amino-9H-purin-9-yl)-2,10,15,16-tetrahydroxy-2,10-dioxooctahydro-2H,10H,12H-5,8-methano-2lambda~5~,10lambda~5~-furo[3,2-l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecin-7-yl]pyrimidine-2,4(1H,3H)-dione |
|